Recent News

LONG RIVER VENTURES PARTICIPATES IN $3M ROUND INTO GATEROCKET INC.
Long River Ventures announced that it has participated in a $3 million Series A financing in GateRocket Inc. of Bedford, Massachusetts. The financing round also included New Atlantic Ventures and Massachusetts Technology Development Corporation (MTDC).

SBA Communications Corporation Announces Closing of Optasite Holding Company Inc. Acquisition.
SBA Communications Corporation (Nasdaq:SBAC) ("SBA") announced that it has completed the acquisition of Optasite Holding Company Inc.

SBA Communications Corporation Agrees to Aquire Optisite Holding Company, Inc.
Long River Ventures, L.P. ("LRV") announced today that SBA Communications Corporation (Nasdaq:SBAC) ("SBA") and Optasite Holding Company Inc. ("Optasite") have entered into a definitive merger agreement under which a newly formed SBA subsidiary will merge with Optasite, which will then become a subsidiary of SBA.

GetWellNetworks launches GetConnected 2008
GetWellNetwork, Inc., a leading provider of Interactive Patient Care (IPC) solutions, today announced the kick-off of GetConnected2008. Designed exclusively for the GetWellNetwork community, GetConnected2008 is the industry's first annual conference focused on IPC technology and improving the patient experience.

SunEthanol receives DOE Funding
SunEthanol's Q Microbe technology is advancing with federal funding as one of only four small-scale biorefinery projects in the country that have just received the support of the U.S. Department of Energy.

Optasite Secures $85 Million In New Financing from Citi, Goldman, and Morgan
Optasite, Inc., a fast-growing developer, owner and operator of telecommunications tower sites, today announced the closing of $85 Million in new financing, including a Series D round of equity led by Citi an a $50M subordinated debt facility from Morgan Stanley.

Verax received 510K approval
Verax Biomedical Inc., a leading developer of rapid tests for detecting bacterial contaminants in blood cells and tissue, has received 510 (k) clearance for its Platelet PGD Test System from the U.S. Food and Drug Administration (FDA).

Phreesia secures $10.25MM Series B Funding
Phreesia Inc™, the first company to provide a free patient-intake solution in the physician's waiting room delivering relevant interactive healthcare content direct-to-patients, announced today the close of a $10.25 million second-round of private financing.